NCT05512377 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05512377
Title	Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Boehringer Ingelheim
Indications	intrahepatic cholangiocarcinoma ampulla of Vater adenocarcinoma urinary bladder cancer gallbladder adenocarcinoma pancreatic ductal adenocarcinoma lung adenocarcinoma cholangiocarcinoma
Therapies	BI 907828
Age Groups:	senior \| adult
Covered Countries	USA \| GBR \| FRA \| ESP \| DEU \| CHE \| BEL \| AUT \| AUS

NCT05512377
Clinical Trial Detail